|Nov 18, 2008 - Seminar with Isabelle Debock|
|Inhibition of Th2 skewed response in neonates promotes the development of Th17 type effector T cells.|
A skewing towards a Th2-type response qualifies today the immunological status of the neonates. This may account for their sensitivity to infectious agents and their propensity to develop allergic pathologies as well as transplantation tolerance. Isabelle Debock and her research team evaluated the effects of the neutralization of IL-4, a key cytokine involved in the development of a Th2-type immune response and in the regulation of IL-17 dependent response, in glance with the possible appearance of a Th17 cell-mediated inflammatory immune response.
Their findings suggest that full acquisition of function by effector Th17 cells may be reinforced when Th2 pathway is prevented early in life. This may have an impact in terms of choice of vaccine adjuvants and development of autoimmune diseases.
|- February 15 : Biopark seminar with Susan Gasser> Read More|
|- February 28 : Bioké formation on flow cytometry> Read More|
|Recent publication in Am J Transplant> Read More|
|CMMI Center for Microscopy and Molecular Imaging|
BioWin Pôle de Compétitivité Santé de Wallon e
IBMM Institut de Biologie et de Médecine Moléculaires
GIGA Groupe Interdisciplinaire de Génoprotéomique Appliquée
Immunehealth provides Services to Biotech Companies and Biopharma in the field of Immunology